Litcius/Paper detail

Comparative effectiveness and safety of eribulin in advanced or metastatic breast cancer: a systematic review and meta-analysis

Kaniz Afroz Tanni, Bang Truong, Brandon Johnson, Jingjing Qian

2021Critical Reviews in Oncology/Hematology17 citationsDOI

Topics & Concepts

EribulinMedicineMetastatic breast cancerOncologyHazard ratioInternal medicineBreast cancerMeta-analysisAdverse effectNeutropeniaChemotherapyConfidence intervalCancerCancer Treatment and PharmacologyHER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies
Comparative effectiveness and safety of eribulin in advanced or metastatic breast cancer: a systematic review and meta-analysis | Litcius